Entries of Vogelhuber, M. on the publication server

Utpatel, K., Calvisi, D. F., Köhler, G., Kühnel, T., Niesel, A., Verloh, N., Vogelhuber, M., Neu, R., Hosten, N., Schildhaus, H.-U., Dietmaier, W. and Evert, M. (2020) Complexity of PEComas. Der Pathologe 41 (S1), pp. 9-19. Fulltext not available.

Utpatel, K., Calvisi, D. F., Köhler, G., Kühnel, T., Niesel, A., Verloh, N., Vogelhuber, M., Neu, R., Hosten, N., Schildhaus, H.-U., Dietmaier, W. and Evert, M. (2019) Komplexität von PEComen. Der Pathologe 40 (4), pp. 443-453. Fulltext not available.

Walter, I., Schulz, U., Vogelhuber, M., Wiedmann, K., Endlicher, E., Klebl, F., Andreesen, R., Herr, W., Ghibelli, L., Hackl, C., Wiest, R. and Reichle, A. (2017) Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial. Medical Oncology 34 (12). Fulltext not available.

Pankrath, A.-L., Weißflog, G., Mehnert, A. , Niederwieser, D., Döhner, H., Hönig, K., Gündel, H., Vogelhuber, M., Friedrich, M. and Ernst, J. (2016) The relation between dyadic coping and relationship satisfaction in couples dealing with haematological cancer. European Journal of Cancer Care 27 (1), e12595. Fulltext not available.

Hart, C., Vogelhuber, M., Hafner, C., Landthaler, M., Berneburg, M., Haferkamp, S., Herr, W. and Reichle, A. (2015) Biomodulatory metronomic therapy in stage IV melanoma is well-tolerated and may induce prolonged progression-free survival, a phase I trial. Journal of the European Academy of Dermatology and Venereology, n/a-n/a. Fulltext not available.

Walter, B., Schrettenbrunner, I., Vogelhuber, M., Grassinger, J., Bross, K., Wilke, J., Suedhoff, T., Berand, A., Wieland, W. F., Rogenhofer, S., Andreesen, R. and Reichle, A. (2012) Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial. Medical Oncology 29 (2), pp. 799-805. Fulltext not available.

Reichle, A., Vogelhuber, M., Feyerabend, S., Suedhoff, T., Schulze, M., Hubner, J., Oberneder, R., Baier, M., Ruebel, A., Birkholz, K., Bakhshandeh-Bath, A. and Andreesen, R. (2011) A phase II study of imatinib with pioglitazone, etoricoxib, dexamethasone, and low-dose treosulfan: Combined anti-inflammatory, immunomodulatory, and angiostatic treatment in patients (pts) with castration-refractory prostate cancer (CRPC). Journal of Clinical Oncology 29 (15_sup), p. 4599. Fulltext not available.

Walter, B., Rogenhofer, S., Vogelhuber, M., Berand, A., Wieland, W. F., Andreesen, R. and Reichle, A. (2010) Modular therapy approach in metastatic castration-refractory prostate cancer. World Journal of Urology 28 (6), pp. 745-750. Fulltext not available.

Albrecht, M., Vogelhuber, M., Stenzl, A., Feyerabend, S., Walter, B., Schulze, M., Oberneder, R., Rohrmann, K., Schmidt, K. and Reichle, A.R. (2008) ANTI-INFLAMMATORY AND ANGIOSTATIC THERAPY IN HORMONE REFRACTORY PROSTATE CANCER (HRPC). European Urology Supplements 7 (3), p. 233. Fulltext not available.

Reichle, A., Walpinski, S., Vogelhuber, M., Wiedmann, K., Berand, A., Endlicher, E., Klebl, F., Schölmerich, J., Andreesen, R. and Wiest, R. (2008) Targeted anti-inflammatory and angiostatic therapy in pretreated patients with advanced hepatocellular carcinoma. Journal of Clinical Oncology 26 (15_sup), p. 15560. Fulltext not available.